More Potent Lipid-Lowering Effect by Rosuvastatin Compared With Fluvastatin in Everolimus-Treated Renal Transplant Recipients-Reference-Cited by-同舟云学术

More Potent Lipid-Lowering Effect by Rosuvastatin Compared With Fluvastatin in Everolimus-Treated Renal Transplant Recipients

Published:2014-06-27 Issue:12 Volume:97 Page:1266-1271
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Robertsen Ida,Åsberg Anders,Granseth Tone,Vethe Nils Tore,Akhlaghi Fatemeh,Ghareeb Mwlod,Molden Espen,Reier-Nilsen Morten,Holdaas Hallvard,Midtvedt Karsten

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference49 articles.

1. Cardiovascular complications after renal transplantation and their prevention.;Ojo;Transplantation,2006

2. Long-term survival in renal transplant recipients with graft function.;Ojo;Kidney Int,2000

3. Ischemic heart diseasemajor cause of death and graft loss after renal transplantation in Scandinavia.;Lindholm;Transplantation,1995

4. Patient survival after renal transplantation; more than 25 years follow-up.;Arend;Nephrol Dial Transplant,1997

5. Metabolic cardiovascular syndrome after renal transplantation.;Hjelmesaeth;Nephrol Dial Transplant,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: Let Us Not Forget the Treatment That Some Patients Have Received—The Brief 50-Year History of a Kidney Transplant Survivor;Frontiers in Medicine;2022-05-24

2. Use of Statins in Kidney Transplant Recipients in Norway;International Journal of Environmental Research and Public Health;2022-01-26

3. Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose and Hemoglobin Concentration in Transplant Patients Treated With Proliferation Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus);Transplantation Proceedings;2020-10

4. Obesity, Fat Tissue Parameters, and Arterial Stiffness in Renal Transplant Recipients;Transplantation Proceedings;2020-10

5. Metabolic Complications and Kidney Transplantation: Focus on Glycaemia and Dyslipidaemia;Current Vascular Pharmacology;2020-04-24